REGATTA PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
REGATTA PHARMA
Largest movements
- Receivables within one year -€225,633
down €225,633 (-75.0%), from €300,719 to €75,086
of which Trade receivables: -€228,616
- Tangible fixed assets -€20,914
down €20,914 (-4.9%), from €425,732 to €404,817
of which Land and buildings: -€22,950
- Cash +€16,433
up €16,433 (+659.5%), from €2,492 to €18,925
mainly Receivables within one year (+€225,633) and Depreciation (+€23,684)
- Accrued charges and deferred income -€139,368
down €139,368 (-76.3%), from €182,724 to €43,356
- Debts after one year -€40,268
down €40,268 (-12.2%), from €329,414 to €289,146
- Trade debts -€30,642
down €30,642 (-90.0%), from €34,028 to €3,386
- Tax, wage and social debts -€19,969
down €19,969 (-68.7%), from €29,070 to €9,100
of which Remuneration and social security: -€10,110
- Profit (loss) carried forward +€11,327
up €11,327 (+3.3%), from -€347,713 to -€336,386
- Gross operating margin -€59,499
down €59,499 (-34.3%), from €173,488 to €113,989
- Staff costs -€51,374
down €51,374 (-41.5%), from €123,689 to €72,316
- Depreciation -€4,186
down €4,186 (-15.0%), from €27,871 to €23,684
- Financial charges -€2,558
down €2,558 (-31.1%), from €8,219 to €5,661
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €816,018 | €589,302 | -€226,716 | -27.8% |
| Fixed assets | 21/28 | €425,807 | €404,893 | -€20,914 | -4.9% |
| Tangible fixed assets | 22/27 | €425,732 | €404,817 | -€20,914 | -4.9% |
| Land and buildings | 22 | €425,619 | €402,669 | -€22,950 | -5.4% |
| Plant, machinery and equipment | 23 | €112 | €2 | -€110 | -98.0% |
| Furniture and vehicles | 24 | €0 | €2,146 | +€2,146 | |
| Financial fixed assets | 28 | €76 | €76 | = | 0.0% |
| Current assets | 29/58 | €390,211 | €184,409 | -€205,802 | -52.7% |
| Stocks and contracts in progress | 3 | €83,345 | €89,895 | +€6,550 | +7.9% |
| Stocks | 30/36 | €83,345 | €89,895 | +€6,550 | +7.9% |
| Amounts receivable within one year | 40/41 | €300,719 | €75,086 | -€225,633 | -75.0% |
| Trade receivables | 40 | €300,623 | €72,008 | -€228,616 | -76.0% |
| Other amounts receivable | 41 | €95 | €3,079 | +€2,983 | +3128.7% |
| Current investments | 50/53 | €0 | - | = | |
| Cash at bank and in hand | 54/58 | €2,492 | €18,925 | +€16,433 | +659.5% |
| Deferred charges and accrued income | 490/1 | €3,656 | €503 | -€3,153 | -86.2% |
| Total equity and liabilities | 10/49 | €816,018 | €589,302 | -€226,716 | -27.8% |
| Equity | 10/15 | -€215,421 | -€204,094 | +€11,327 | +5.3% |
| Contributions | 10/11 | €20,000 | €20,000 | = | 0.0% |
| Reserves | 13 | €112,292 | €112,292 | = | 0.0% |
| Non-distributable reserves | 130/1 | €2,000 | €0 | -€2,000 | -100.0% |
| Reserves not available under the articles | 1311 | €2,000 | €0 | -€2,000 | -100.0% |
| Distributable reserves | 133 | €110,292 | €112,292 | +€2,000 | +1.8% |
| Profit (loss) carried forward | 14 | -€347,713 | -€336,386 | +€11,327 | +3.3% |
| Amounts payable | 17/49 | €1,031,439 | €793,396 | -€238,043 | -23.1% |
| Amounts payable after more than one year | 17 | €329,414 | €289,146 | -€40,268 | -12.2% |
| Financial debts | 170/4 | €329,414 | €289,146 | -€40,268 | -12.2% |
| Amounts payable within one year | 42/48 | €519,301 | €460,893 | -€58,407 | -11.2% |
| Current portion of amounts payable after more than one year | 42 | €39,764 | €40,328 | +€564 | +1.4% |
| Financial debts | 43 | €50,000 | €50,000 | = | 0.0% |
| Credit institutions | 430/8 | €50,000 | €50,000 | = | 0.0% |
| Trade debts | 44 | €34,028 | €3,386 | -€30,642 | -90.0% |
| Suppliers | 440/4 | €34,028 | €3,386 | -€30,642 | -90.0% |
| Taxes, remuneration and social security | 45 | €29,070 | €9,100 | -€19,969 | -68.7% |
| Taxes | 450/3 | €9,859 | €0 | -€9,859 | -100.0% |
| Remuneration and social security | 454/9 | €19,210 | €9,100 | -€10,110 | -52.6% |
| Other amounts payable | 47/48 | €366,439 | €358,079 | -€8,360 | -2.3% |
| Accrued charges and deferred income | 492/3 | €182,724 | €43,356 | -€139,368 | -76.3% |
| Non-recurring operating income | 76A | €0 | €180 | +€180 | |
| Remuneration, social security and pensions | 62 | €123,689 | €72,316 | -€51,374 | -41.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €27,871 | €23,684 | -€4,186 | -15.0% |
| Other operating charges | 640/8 | €2,724 | €2,091 | -€633 | -23.3% |
| Non-recurring operating charges | 66A | €2,184 | €0 | -€2,184 | -100.0% |
| Gross operating margin | 9900 | €173,488 | €113,989 | -€59,499 | -34.3% |
| Operating profit (loss) | 9901 | €17,020 | €15,899 | -€1,121 | -6.6% |
| Financial income | 75/76B | €1,358 | €1,090 | -€269 | -19.8% |
| Recurring financial income | 75 | €1,358 | €1,090 | -€269 | -19.8% |
| Financial charges | 65/66B | €8,219 | €5,661 | -€2,558 | -31.1% |
| Recurring financial charges | 65 | €8,219 | €5,661 | -€2,558 | -31.1% |
| Profit (loss) for the period before taxes | 9903 | €10,159 | €11,327 | +€1,168 | +11.5% |
| Profit (loss) for the period | 9904 | €10,159 | €11,327 | +€1,168 | +11.5% |
| Profit (loss) for the period to be appropriated | 9905 | €10,159 | €11,327 | +€1,168 | +11.5% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 10 October 2026 via checked.be.